Biogen priced its newly approved medicine Aduhelm at an average cost of $56,000 a year. Cigna, which estimates out-of-pocket costs may hit $10,000, is working on a value-based payment agreement with the drugmaker.
Biogen priced its newly approved medicine Aduhelm at an average cost of $56,000 a year. Cigna, which estimates out-of-pocket costs may hit $10,000, is working on a value-based payment agreement with the drugmaker.
Copyright © 2024 | WordPress Theme by MH Themes